Source: Health Canada shortage reports · Updated Jul 13, 2026
A shortage of Etoposide is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
Products affected
0 / 3
Reports on file
20
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Anticipated
VEPESID
50MG · CAPSULE · CHEPLAPHARM ARZNEIMITTEL GMBH
DIN 00616192 · Disruption of the manufacture of the drug.
Resolved
ETOPOSIDE INJECTION
20MG · LIQUID · TEVA CANADA LIMITED
DIN 02080036 · ended Jul 27, 2023 · Disruption of the manufacture of the drug.
Resolved
ETOPOSIDE INJECTION
20MG · LIQUID · TEVA CANADA LIMITED
DIN 02080036 · ended Jun 8, 2023 · Disruption of the manufacture of the drug.
Resolved
ETOPOSIDE INJECTION
20MG · LIQUID · TEVA CANADA LIMITED
DIN 02080036 · ended Feb 7, 2023 · Disruption of the manufacture of the drug.
Resolved
ETOPOSIDE INJECTION USP
20MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02380935 · ended Jul 13, 2022 · Requirements related to complying with good manufacturing practices.
Resolved
ETOPOSIDE INJECTION USP
20MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02380935 · ended Jul 13, 2022 · Requirements related to complying with good manufacturing practices.
Resolved
ETOPOSIDE INJECTION USP
20MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02380935 · ended Jul 13, 2022 · Requirements related to complying with good manufacturing practices.
Resolved
ETOPOSIDE INJECTION USP
20MG · SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02380935 · ended Jul 13, 2022 · Requirements related to complying with good manufacturing practices.
Resolved
ETOPOSIDE INJECTION
20MG · LIQUID · TEVA CANADA LIMITED
DIN 02080036 · ended Nov 6, 2020 · Disruption of the manufacture of the drug.
Resolved
ETOPOSIDE INJECTION
20MG · LIQUID · TEVA CANADA LIMITED
DIN 02080036 · ended Mar 15, 2020 · Demand increase for the drug.
Resolved
ETOPOSIDE INJECTION
20MG · LIQUID · TEVA CANADA LIMITED
DIN 02080036 · ended Mar 15, 2020 · Demand increase for the drug.
Resolved
ETOPOSIDE INJECTION
20MG · LIQUID · TEVA CANADA LIMITED
DIN 02080036 · ended Mar 15, 2020 · Demand increase for the drug.
Showing 12 of 20 reports. All reports are on file with Health Canada.
What's happening
A manufacturer has told Health Canada it expects supply of Etoposide to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.
Etoposide is classified under “PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS” (ATC L01CB).
Recent changes
Jul 13, 2026
New report filed
Common questions
When will Etoposide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Etoposide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.